Cavitation Technologies, Inc. and Desmet Belgium S.A Sign Agreement That Will Allow CTi to Monetize Parts of Its IP Portfolio While Retaining Worldwide Exclusive Licenses in Its Primary Business Lines

In This Article:

Cavitation Technologies, Inc
Cavitation Technologies, Inc

CHATSWORTH, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Cavitation Technologies, Inc. ("CTi" or the "Company") (OTCQB:CVAT), a leading ESG company designing and manufacturing innovative flow-through nano-technology systems for fluid processing applications worldwide, has entered into an agreement with Desmet Belgium S.A. (formerly Desmet Group S.A.) (“Desmet”) that, once the transaction is completed, will monetize for the Company certain of its U.S. and non-U.S. patents and related intellectual property that for several years have been licensed to Desmet for its use on a global basis in vegetable oil, fats and oleo applications.

Under the agreement signed today, the Company will assign and transfer to Desmet several U.S. and non-U.S. patents and associated technical information that are currently licensed to Desmet (the “Assigned Patents”). The Company will also assign to Desmet ownership of two U.S. trademark registrations that CTi holds for its Nano Neutralization® and Nano Reactor® marks, respectively (the “Assigned Marks”).

Under the agreement, with the patent assignment to Desmet, the Company will reserve to itself, and will receive a license back, of a worldwide, exclusive, transferable and royalty-free license and right to practice and use the Assigned Patents and associated technical information in businesses, activities, projects, uses and applications (1) in the field of water and wastewater processing, recovery, recycling and purification (including oilfield wastewater), and/or (2) the field of the manufacture, distillation, brewing, enhancements, sale and marketing of alcoholic beverages (the “Licensed Fields”). Under the reserved and grant-back licenses retained and received by the Company under the agreement, the Company will have a worldwide, exclusive, transferable and royalty-free license and right to design, build, use, export, improve, sell and market Nano Reactor® devices and Nano Reactor® devices and systems (and products) that incorporate or utilize Nano Reactor® devices, in each case within the Licensed Fields, and to continue to use the Nano Reactor® trademark in connection with its business, systems and products within the Licensed Fields.

Commenting favorably on the transaction, Neil Voloshin, CTi’s CEO, offered the following:

“Once completed, this transaction will enable the Company to monetize the value of the IP rights already under license to Desmet, while at the same time retaining a full range of exclusive licenses and rights required by the Company to continue the development of business partnerships, projects and opportunities in our primary lines of business. It will also generate substantial capital for the Company, providing support for our current business plans, without any dilution of our shareholders.”